5-bromo-3-(2,3-dichlorophenyl)-6-(4,4-dimethylpiperidin-1-yl)pyrazin-2-amine;5-chloro-3-(2,3-dichlorophenyl)-6-(4,4-dimethylpiperidin-1-yl)pyrazin-2-amine;3-(2,3-dichlorophenyl)-6-(4,4-dimethylpiperidin-1-yl)-5-methylpyrazin-2-amine;6-(2,3-dichlorophenyl)-3-(4,4-dimethylpiperidin-1-yl)-1,2,4-triazin-5-amine;3-(2,3-dichlorophenyl)-6-(4-ethylpiperidin-1-yl)pyrazin-2-amine

C85H99BrCl11N21 — CID 160542933

IUPAC5-bromo-3-(2,3-dichlorophenyl)-6-(4,4-dimethylpiperidin-1-yl)pyrazin-2-amine;5-chloro-3-(2,3-dichlorophenyl)-6-(4,4-dimethylpiperidin-1-yl)pyrazin-2-amine;3-(2,3-dichlorophenyl)-6-(4,4-dimethylpiperidin-1-yl)-5-methylpyrazin-2-amine;6-(2,3-dichlorophenyl)-3-(4,4-dimethylpiperidin-1-yl)-1,2,4-triazin-5-amine;3-(2,3-dichlorophenyl)-6-(4-ethylpiperidin-1-yl)pyrazin-2-amine
SMILESCC1(C)CCN(c2nc(N)c(-c3cccc(Cl)c3Cl)nc2Br)CC1.CC1(C)CCN(c2nc(N)c(-c3cccc(Cl)c3Cl)nc2Cl)CC1.CC1(C)CCN(c2nnc(-c3cccc(Cl)c3Cl)c(N)n2)CC1.CCC1CCN(c2cnc(-c3cccc(Cl)c3Cl)c(N)n2)CC1.Cc1nc(-c2cccc(Cl)c2Cl)c(N)nc1N1CCC(C)(C)CC1
InChIInChI=1S/C18H22Cl2N4.C17H19BrCl2N4.C17H19Cl3N4.C17H20Cl2N4.C16H19Cl2N5/c1-11-17(24-9-7-18(2,3)8-10-24)23-16(21)15(22-11)12-5-4-6-13(19)14(12)20;1-17(2)6-8-24(9-7-17)16-14(18)22-13(15(21)23-16)10-4-3-5-11(19)12(10)20;1-17(2)6-8-24(9-7-17)16-14(20)22-13(15(21)23-16)10-4-3-5-11(18)12(10)19;1-2-11-6-8-23(9-7-11)14-10-21-16(17(20)22-14)12-4-3-5-13(18)15(12)19;1-16(2)6-8-23(9-7-16)15-20-14(19)13(21-22-15)10-4-3-5-11(17)12(10)18/h4-6H,7-10H2,1-3H3,(H2,21,23);2*3-5H,6-9H2,1-2H3,(H2,21,23);3-5,10-11H,2,6-9H2,1H3,(H2,20,22);3-5H,6-9H2,1-2H3,(H2,19,20,22)
InChIKeyQXANIQSGQVJWHP-UHFFFAOYSA-N
MW1884.76 g/mol
LogP24.41
Rot. Bonds11

About 5-bromo-3-(2,3-dichlorophenyl)-6-(4,4-dimethylpiperidin-1-yl)pyrazin-2-amine;5-chloro-3-(2,3-dichlorophenyl)-6-(4,4-dimethylpiperidin-1-yl)pyrazin-2-amine;3-(2,3-dichlorophenyl)-6-(4,4-dimethylpiperidin-1-yl)-5-methylpyrazin-2-amine;6-(2,3-dichlorophenyl)-3-(4,4-dimethylpiperidin-1-yl)-1,2,4-triazin-5-amine;3-(2,3-dichlorophenyl)-6-(4-ethylpiperidin-1-yl)pyrazin-2-amine

5-bromo-3-(2,3-dichlorophenyl)-6-(4,4-dimethylpiperidin-1-yl)pyrazin-2-amine;5-chloro-3-(2,3-dichlorophenyl)-6-(4,4-dimethylpiperidin-1-yl)pyrazin-2-amine;3-(2,3-dichlorophenyl)-6-(4,4-dimethylpiperidin-1-yl)-5-methylpyrazin-2-amine;6-(2,3-dichlorophenyl)-3-(4,4-dimethylpiperidin-1-yl)-1,2,4-triazin-5-amine;3-(2,3-dichlorophenyl)-6-(4-ethylpiperidin-1-yl)pyrazin-2-amine (PubChem CID 160542933) has the molecular formula C85H99BrCl11N21 and a molecular weight of 1884.76 g/mol. Its IUPAC name is 5-bromo-3-(2,3-dichlorophenyl)-6-(4,4-dimethylpiperidin-1-yl)pyrazin-2-amine;5-chloro-3-(2,3-dichlorophenyl)-6-(4,4-dimethylpiperidin-1-yl)pyrazin-2-amine;3-(2,3-dichlorophenyl)-6-(4,4-dimethylpiperidin-1-yl)-5-methylpyrazin-2-amine;6-(2,3-dichlorophenyl)-3-(4,4-dimethylpiperidin-1-yl)-1,2,4-triazin-5-amine;3-(2,3-dichlorophenyl)-6-(4-ethylpiperidin-1-yl)pyrazin-2-amine.

Molecular Properties

Compound Name5-bromo-3-(2,3-dichlorophenyl)-6-(4,4-dimethylpiperidin-1-yl)pyrazin-2-amine;5-chloro-3-(2,3-dichlorophenyl)-6-(4,4-dimethylpiperidin-1-yl)pyrazin-2-amine;3-(2,3-dichlorophenyl)-6-(4,4-dimethylpiperidin-1-yl)-5-methylpyrazin-2-amine;6-(2,3-dichlorophenyl)-3-(4,4-dimethylpiperidin-1-yl)-1,2,4-triazin-5-amine;3-(2,3-dichlorophenyl)-6-(4-ethylpiperidin-1-yl)pyrazin-2-amine
PubChem CID160542933
Molecular FormulaC85H99BrCl11N21
Molecular Weight1884.76 g/mol
Exact Mass1877.41
IUPAC Name5-bromo-3-(2,3-dichlorophenyl)-6-(4,4-dimethylpiperidin-1-yl)pyrazin-2-amine;5-chloro-3-(2,3-dichlorophenyl)-6-(4,4-dimethylpiperidin-1-yl)pyrazin-2-amine;3-(2,3-dichlorophenyl)-6-(4,4-dimethylpiperidin-1-yl)-5-methylpyrazin-2-amine;6-(2,3-dichlorophenyl)-3-(4,4-dimethylpiperidin-1-yl)-1,2,4-triazin-5-amine;3-(2,3-dichlorophenyl)-6-(4-ethylpiperidin-1-yl)pyrazin-2-amine
SMILESCC1(C)CCN(c2nc(N)c(-c3cccc(Cl)c3Cl)nc2Br)CC1.CC1(C)CCN(c2nc(N)c(-c3cccc(Cl)c3Cl)nc2Cl)CC1.CC1(C)CCN(c2nnc(-c3cccc(Cl)c3Cl)c(N)n2)CC1.CCC1CCN(c2cnc(-c3cccc(Cl)c3Cl)c(N)n2)CC1.Cc1nc(-c2cccc(Cl)c2Cl)c(N)nc1N1CCC(C)(C)CC1
InChIInChI=1S/C18H22Cl2N4.C17H19BrCl2N4.C17H19Cl3N4.C17H20Cl2N4.C16H19Cl2N5/c1-11-17(24-9-7-18(2,3)8-10-24)23-16(21)15(22-11)12-5-4-6-13(19)14(12)20;1-17(2)6-8-24(9-7-17)16-14(18)22-13(15(21)23-16)10-4-3-5-11(19)12(10)20;1-17(2)6-8-24(9-7-17)16-14(20)22-13(15(21)23-16)10-4-3-5-11(18)12(10)19;1-2-11-6-8-23(9-7-11)14-10-21-16(17(20)22-14)12-4-3-5-13(18)15(12)19;1-16(2)6-8-23(9-7-16)15-20-14(19)13(21-22-15)10-4-3-5-11(17)12(10)18/h4-6H,7-10H2,1-3H3,(H2,21,23);2*3-5H,6-9H2,1-2H3,(H2,21,23);3-5,10-11H,2,6-9H2,1H3,(H2,20,22);3-5H,6-9H2,1-2H3,(H2,19,20,22)
InChIKeyQXANIQSGQVJWHP-UHFFFAOYSA-N
XLogP24.41
TPSA288.09 Ų
H-Bond Donors5
H-Bond Acceptors21
Rotatable Bonds11
Heavy Atoms118
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001884.76
LogP ≤ 524.41
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1021

Analyze 5-bromo-3-(2,3-dichlorophenyl)-6-(4,4-dimethylpiperidin-1-yl)pyrazin-2-amine;5-chloro-3-(2,3-dichlorophenyl)-6-(4,4-dimethylpiperidin-1-yl)pyrazin-2-amine;3-(2,3-dichlorophenyl)-6-(4,4-dimethylpiperidin-1-yl)-5-methylpyrazin-2-amine;6-(2,3-dichlorophenyl)-3-(4,4-dimethylpiperidin-1-yl)-1,2,4-triazin-5-amine;3-(2,3-dichlorophenyl)-6-(4-ethylpiperidin-1-yl)pyrazin-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 5-bromo-3-(2,3-dichlorophenyl)-6-(4,4-dimethylpiperidin-1-yl)pyrazin-2-amine;5-chloro-3-(2,3-dichlorophenyl)-6-(4,4-dimethylpiperidin-1-yl)pyrazin-2-amine;3-(2,3-dichlorophenyl)-6-(4,4-dimethylpiperidin-1-yl)-5-methylpyrazin-2-amine;6-(2,3-dichlorophenyl)-3-(4,4-dimethylpiperidin-1-yl)-1,2,4-triazin-5-amine;3-(2,3-dichlorophenyl)-6-(4-ethylpiperidin-1-yl)pyrazin-2-amine?
The IUPAC name of 5-bromo-3-(2,3-dichlorophenyl)-6-(4,4-dimethylpiperidin-1-yl)pyrazin-2-amine;5-chloro-3-(2,3-dichlorophenyl)-6-(4,4-dimethylpiperidin-1-yl)pyrazin-2-amine;3-(2,3-dichlorophenyl)-6-(4,4-dimethylpiperidin-1-yl)-5-methylpyrazin-2-amine;6-(2,3-dichlorophenyl)-3-(4,4-dimethylpiperidin-1-yl)-1,2,4-triazin-5-amine;3-(2,3-dichlorophenyl)-6-(4-ethylpiperidin-1-yl)pyrazin-2-amine (CID 160542933) is 5-bromo-3-(2,3-dichlorophenyl)-6-(4,4-dimethylpiperidin-1-yl)pyrazin-2-amine;5-chloro-3-(2,3-dichlorophenyl)-6-(4,4-dimethylpiperidin-1-yl)pyrazin-2-amine;3-(2,3-dichlorophenyl)-6-(4,4-dimethylpiperidin-1-yl)-5-methylpyrazin-2-amine;6-(2,3-dichlorophenyl)-3-(4,4-dimethylpiperidin-1-yl)-1,2,4-triazin-5-amine;3-(2,3-dichlorophenyl)-6-(4-ethylpiperidin-1-yl)pyrazin-2-amine.
What is the SMILES notation for 5-bromo-3-(2,3-dichlorophenyl)-6-(4,4-dimethylpiperidin-1-yl)pyrazin-2-amine;5-chloro-3-(2,3-dichlorophenyl)-6-(4,4-dimethylpiperidin-1-yl)pyrazin-2-amine;3-(2,3-dichlorophenyl)-6-(4,4-dimethylpiperidin-1-yl)-5-methylpyrazin-2-amine;6-(2,3-dichlorophenyl)-3-(4,4-dimethylpiperidin-1-yl)-1,2,4-triazin-5-amine;3-(2,3-dichlorophenyl)-6-(4-ethylpiperidin-1-yl)pyrazin-2-amine?
The canonical SMILES for 5-bromo-3-(2,3-dichlorophenyl)-6-(4,4-dimethylpiperidin-1-yl)pyrazin-2-amine;5-chloro-3-(2,3-dichlorophenyl)-6-(4,4-dimethylpiperidin-1-yl)pyrazin-2-amine;3-(2,3-dichlorophenyl)-6-(4,4-dimethylpiperidin-1-yl)-5-methylpyrazin-2-amine;6-(2,3-dichlorophenyl)-3-(4,4-dimethylpiperidin-1-yl)-1,2,4-triazin-5-amine;3-(2,3-dichlorophenyl)-6-(4-ethylpiperidin-1-yl)pyrazin-2-amine is CC1(C)CCN(c2nc(N)c(-c3cccc(Cl)c3Cl)nc2Br)CC1.CC1(C)CCN(c2nc(N)c(-c3cccc(Cl)c3Cl)nc2Cl)CC1.CC1(C)CCN(c2nnc(-c3cccc(Cl)c3Cl)c(N)n2)CC1.CCC1CCN(c2cnc(-c3cccc(Cl)c3Cl)c(N)n2)CC1.Cc1nc(-c2cccc(Cl)c2Cl)c(N)nc1N1CCC(C)(C)CC1.
What is the InChIKey of 5-bromo-3-(2,3-dichlorophenyl)-6-(4,4-dimethylpiperidin-1-yl)pyrazin-2-amine;5-chloro-3-(2,3-dichlorophenyl)-6-(4,4-dimethylpiperidin-1-yl)pyrazin-2-amine;3-(2,3-dichlorophenyl)-6-(4,4-dimethylpiperidin-1-yl)-5-methylpyrazin-2-amine;6-(2,3-dichlorophenyl)-3-(4,4-dimethylpiperidin-1-yl)-1,2,4-triazin-5-amine;3-(2,3-dichlorophenyl)-6-(4-ethylpiperidin-1-yl)pyrazin-2-amine?
The InChIKey is QXANIQSGQVJWHP-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H22Cl2N4.C17H19BrCl2N4.C17H19Cl3N4.C17H20Cl2N4.C16H19Cl2N5/c1-11-17(24-9-7-18(2,3)8-10-24)23-16(21)15(22-11)12-5-4-6-13(19)14(12)20;1-17(2)6-8-24(9-7-17)16-14(18)22-13(15(21)23-16)10-4-3-5-11(19)12(10)20;1-17(2)6-8-24(9-7-17)16-14(20)22-13(15(21)23-16)10-4-3-5-11(18)12(10)19;1-2-11-6-8-23(9-7-11)14-10-21-16(17(20)22-14)12-4-3-5-13(18)15(12)19;1-16(2)6-8-23(9-7-16)15-20-14(19)13(21-22-15)10-4-3-5-11(17)12(10)18/h4-6H,7-10H2,1-3H3,(H2,21,23);2*3-5H,6-9H2,1-2H3,(H2,21,23);3-5,10-11H,2,6-9H2,1H3,(H2,20,22);3-5H,6-9H2,1-2H3,(H2,19,20,22).
What are the key properties of 5-bromo-3-(2,3-dichlorophenyl)-6-(4,4-dimethylpiperidin-1-yl)pyrazin-2-amine;5-chloro-3-(2,3-dichlorophenyl)-6-(4,4-dimethylpiperidin-1-yl)pyrazin-2-amine;3-(2,3-dichlorophenyl)-6-(4,4-dimethylpiperidin-1-yl)-5-methylpyrazin-2-amine;6-(2,3-dichlorophenyl)-3-(4,4-dimethylpiperidin-1-yl)-1,2,4-triazin-5-amine;3-(2,3-dichlorophenyl)-6-(4-ethylpiperidin-1-yl)pyrazin-2-amine?
5-bromo-3-(2,3-dichlorophenyl)-6-(4,4-dimethylpiperidin-1-yl)pyrazin-2-amine;5-chloro-3-(2,3-dichlorophenyl)-6-(4,4-dimethylpiperidin-1-yl)pyrazin-2-amine;3-(2,3-dichlorophenyl)-6-(4,4-dimethylpiperidin-1-yl)-5-methylpyrazin-2-amine;6-(2,3-dichlorophenyl)-3-(4,4-dimethylpiperidin-1-yl)-1,2,4-triazin-5-amine;3-(2,3-dichlorophenyl)-6-(4-ethylpiperidin-1-yl)pyrazin-2-amine has a molecular weight of 1884.76 g/mol, XLogP of 24.41, 11 rotatable bonds, 5 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for 5-bromo-3-(2,3-dichlorophenyl)-6-(4,4-dimethylpiperidin-1-yl)pyrazin-2-amine;5-chloro-3-(2,3-dichlorophenyl)-6-(4,4-dimethylpiperidin-1-yl)pyrazin-2-amine;3-(2,3-dichlorophenyl)-6-(4,4-dimethylpiperidin-1-yl)-5-methylpyrazin-2-amine;6-(2,3-dichlorophenyl)-3-(4,4-dimethylpiperidin-1-yl)-1,2,4-triazin-5-amine;3-(2,3-dichlorophenyl)-6-(4-ethylpiperidin-1-yl)pyrazin-2-amine is sourced from PubChem (CID 160542933), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).